We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





New Inkjet-Printed Diagnostics-on-Demand Demonstrated at AACC 2015

By LabMedica International staff writers
Posted on 17 Aug 2015
Print article
Image: The new “XylemDx” inkjet printing based technology turns a sheet of paper into any one of a variety of rapid, lower-cost tests. Each can be configured with a custom set of test modules before being folded concertina-style into the traditional test cartridge shape (Photo courtesy of Cambridge Consultants).
Image: The new “XylemDx” inkjet printing based technology turns a sheet of paper into any one of a variety of rapid, lower-cost tests. Each can be configured with a custom set of test modules before being folded concertina-style into the traditional test cartridge shape (Photo courtesy of Cambridge Consultants).
Image: Example of an open diagnostic test cartridge made using the breakthrough “XylemDx” inkjet printing based technology to custom-print any one of a variety of test modules onto a single sheet of paper (Photo courtesy of Cambridge Consultants).
Image: Example of an open diagnostic test cartridge made using the breakthrough “XylemDx” inkjet printing based technology to custom-print any one of a variety of test modules onto a single sheet of paper (Photo courtesy of Cambridge Consultants).
An inkjet-based innovation for high-tech printing on paper opens the door to lower cost, rapid (point-of-care) POC testing, and was demonstrated during the 2015 AACC Meeting & Clinical Lab Expo (July 26-30; Atlanta, GA, USA).

The new XylemDx technology developed Cambridge Consultants (Cambridge, UK) is set to bring a breakthrough innovation to POC diagnostics. Ingenious use of inkjet printing techniques has made it possible to create a test cartridge from a single sheet of paper, paving the way for sophisticated low-cost tests that can be adapted at the touch of a button. Also, the digital fabrication technique (once regulatory approval is secured) will give the flexibility to print tests in quantities from one to millions.

Aging populations, the drive for healthcare efficiency, and the rapid rise of “consumer healthcare”—where people manage their own health and well-being—are fueling an increase in POC diagnostics. But the high cost of POC tests compared with centralized lab tests is a challenge. XylemDx enables simple, low-cost, near-instant personalized testing, for example, at the pharmacy or doctor’s surgery, for signs ranging from the latest strain of the flu virus to biomarkers for genetic conditions. In developing countries, it could play a crucial role in mobile-clinic diagnostics and in pandemic monitoring and screening of large populations during an outbreak of Ebola, for example.

XylemDx turns a sheet of paper into any one of a variety of different tests, each of which can be produced on the same fabrication device. Each test paper can be configured with a custom set of test modules (such as electronic, thermal, fluidic, optical, or biological reagent modules) before being folded concertina-style into the traditional test cartridge shape. For diagnostic manufacturers, this opens up the possibility of low-cost prototyping and development, as well as a universal production methodology. The modules “toolbox” enables customization for a particular patient or specific strain of disease.

The test modules are printed with inkjet-based printing techniques that use wax to lay down fluidic pathways, electronic ink containing silver nanoparticles to allow electrical connectivity, and so on. The paper cartridges can be configured for various samples types (such as blood, urine, saliva, or mucus) and various readers (from complex diagnostic instruments to a reader on the back of a smartphone or a simple USB-powered device).

“Diagnostic tests underpin crucial healthcare decisions so it’s vital they are as fast, accurate, flexible, and cost-effective as possible,” said John Pritchard, head of diagnostics at Cambridge Consultants, “Cambridge Consultants has a rich history of inkjet printing and we’ve now brought that expertise to the world of POC diagnostics. Combined with our extensive scientific and engineering knowledge—including our long track record in the low-cost, high-performance optics that many of these tests require—it’s resulted in a radical new way of providing diagnostics on demand.”

Related Links:

Cambridge Consultants


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Myeloperoxidase Assay
IDK MPO ELISA
New
Silver Member
ACTH Assay
ACTH ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.